1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Type 2 diabetes candidate genes, including PAX5, cause impaired insulin secretion in human pancreatic islets
(
- Contribution to journal › Article
- 2022
-
Mark
Secretory granule exocytosis and its amplification by cAMP in pancreatic β-cells
(
- Contribution to journal › Scientific review
- 2020
-
Mark
A short peptide of the C-terminal class Y helices of apolipoprotein A-I has preserved functions in cholesterol efflux and in vivo metabolic control
(
- Contribution to journal › Article
-
Mark
ApoA-1 improves glucose tolerance by increasing glucose uptake into heart and skeletal muscle independently of AMPKα2
(
- Contribution to journal › Article
- 2019
-
Mark
Loss of ZnT8 function protects against diabetes by enhanced insulin secretion
(
- Contribution to journal › Article
-
Mark
Novel ABCA1 peptide agonists with antidiabetic action
(
- Contribution to journal › Article
- 2016
-
Mark
Dual actions of apolipoprotein A-I on glucose-stimulated insulin secretion and insulin-independent peripheral tissue glucose uptake lead to increased heart and skeletal muscle glucose disposal
(
- Contribution to journal › Article
- 2014
-
Mark
Single injections of apoA-I acutely improve in vivo glucose tolerance in insulin-resistant mice.
(
- Contribution to journal › Article
- 2012
-
Mark
The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils.
(
- Contribution to journal › Article